Rho Kinase Inhibitors and Novel Ocular Drug Delivery Systems- A Revolutionary Step Towards the Treatment of Glaucoma

E-ISSN： 1875-5704|13|6|818-829

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.13, Iss.6, 2016-09, pp. : 818-829

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rho-kinase inhibitors offer a new approach in the treatment of glaucoma

By Challa Pratap Arnold John J

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 81-95

Informa Healthcare

Access to resources Recommend Favorite

Serotonin-2 Receptor Agonists as Novel Ocular Hypotensive Agents and their Cellular and Molecular Mechanisms of Action: Novel Drug Targets for Glaucoma Treatment

Current Drug Targets, Vol. 11, Iss. 8, 2010-01 ,pp. : 978-993

Bentham Science Publishers

Access to resources Recommend Favorite

Vesicular systems in ocular drug delivery: an overview

By Kaur I.P. Garg A. Singla A.K. Aggarwal D.

International Journal of Pharmaceutics, Vol. 269, Iss. 1, 2004-01 ,pp. : 1-14

Elsevier

Access to resources Recommend Favorite

Rho-Kinase as a Drug Target for the Treatment of Airway Hyperresponsiveness in Asthma

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-03 ,pp. : 339-348

Bentham Science Publishers

Access to resources Recommend Favorite

Development of novel drug delivery systems

By Shao J.

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 47-48

Elsevier

Access to resources Recommend Favorite